Holen Sie sich die Stockscreener-App
1.14
3.64%
0.04
Handel nachbörslich:
1.15
0.01
+0.88%
Genprex Inc Aktie (GNPX) Neueste Nachrichten
Genprex links with University of Michigan on lung cancer treatment - Yahoo Finance
Genprex secures exclusive gene therapy license for cancer By Investing.com - Investing.com Canada
Genprex secures exclusive gene therapy license for cancer - Investing.com India
Genprex Signs Exclusive License to Additional Gene Therapy Technologies with the University of Michigan for the Treatment of Lung Cancer - PR Newswire
Genprex faces Nasdaq delisting over equity shortfall By Investing.com - Investing.com Australia
Genprex faces Nasdaq delisting over equity shortfall - Investing.com
U.S. Stock market top gainers: Mullen Automotive gains 92.92% while Genprex increases by 54.48% during mid day trading - Business Upturn
Genprex reports promising preclinical data on cancer therapy - Investing.com
Genprex Collaborators Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting - BioSpace
Genprex Featured in CEO/CFO Magazine Discussing Novel Gene Thera - GuruFocus.com
Genprex regains Nasdaq compliance with bid price rule - Investing.com India
Genprex regains Nasdaq compliance with bid price rule By Investing.com - Investing.com Australia
Genprex reports promising preclinical data on cancer therapy By Investing.com - Investing.com UK
Genprex Announces Sponsored Research Agreement with The Universi - GuruFocus.com
Short Interest in Genprex, Inc. (NASDAQ:GNPX) Increases By 5.2% - Defense World
Genprex to Participate in 2024 BIO Europe Conference - The Malaysian Reserve
Investor Excitement Sparks Genprex (GNPX) Stock Rally - Stocks Telegraph
Genprex reports positive preclinical gene therapy data By Investing.com - Investing.com South Africa
Genprex reports positive preclinical gene therapy data - Investing.com India
Genprex Collaborators Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer, Mesothelioma and Glioblastoma - The Malaysian Reserve
Genprex (NASDAQ:GNPX) Announces Sponsored Research Agreement with University of Michigan Rogel Cancer Center for Study on TUSC2 Gene Therapy in ALK-Positive Lung Cancer Patients - Defense World
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - MSN
Genprex explores gene therapy in lung cancer study - Investing.com India
Genprex explores gene therapy in lung cancer study By Investing.com - Investing.com South Africa
Genprex signs two lung cancer research agreements - TipRanks
Genprex Announces Sponsored Research Agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive - StreetInsider.com
3 Penny Stocks to Watch Now, 10/24/24 - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.02% - MSN
2 No-Brainer Artificial Intelligence (AI) Stocks to Buy Right Now - Yahoo Finance
Dow Falls Over 150 Points; General Motors Tops Q3 Views - Benzinga
‘Permanent should mean Permanent’: Purbeck calls for commitment to Full Expensing - Yahoo! Voices
TD Bank becomes liquidity provider for LTX - Yahoo! Voices
UK economy 'set to accelerate', says IMF - Yahoo! Voices
IMF's economic view: A brighter outlook for US but still-tepid global growth - Yahoo! Voices
Scotch whisky business Compass Box in overseas push - Yahoo News
Siemens secures contract to optimise Unibuss’ electric fleet with Depot360 - Yahoo! Voices
US dough business Urban Farmer appoints Chris Jaromin as new CEO - Yahoo! Voices
DHL Supply Chain to close Canal Winchester warehouse, lay off more than 150 workers - Yahoo News
QC Copper to acquire remaining 50% of Roger Gold-Copper Project - Yahoo! Voices
CAC introduces cyber cover for energy and utility sectors - Yahoo! Voices
How small Canadian retailers are thriving on multiple sales channels - Yahoo! Voices
Zymeworks doses first subject in Phase I trial of ZW171 for various forms of cancer - Yahoo! Voices
2 Low-Cost Vanguard ETFs for Set-and-Forget Investors - Yahoo! Voices
Eleven unveils AI-driven software tailored for accounting - Yahoo News
Excelsior gets final permit for Arizona copper mine operations - Yahoo News
The Dean Group acquires 280-room Roomer’s Munich hotel - Yahoo! Voices
JCP urges Cheesecake to spin off three brands for growth - Yahoo! Voices
Kmart just closed its last full store — but there’s still a location in Kendall - Yahoo! Voices
These Are the 5 Most Shorted Stocks in the S&P 500 Index. The Bears Are Wrong About 1 of Them. - Yahoo! Voices
This Big Social Security Change Was Just Announced, and It Will Affect Your 2025 Benefits - Yahoo! Voices
HSBC splits up bank amid growing tensions between China and the West - Yahoo! Voices
Regeneron Pharmaceuticals (REGN) Stock Drops Amid Market Volatility - GuruFocus.com
Shari's Cafe & Pies appears to close all remaining Oregon locations - Yahoo! Voices
UK plans to ease ring-fencing regulations for banks to boost competitiveness - Yahoo! Voices
Rothschild & Co leads M&A financial advisory in Middle East & Africa for Q1-Q3 2024 - Yahoo! Voices
Allen & Overy leads M&A legal advisory in Middle East & Africa in Q1-Q3 2024 - Yahoo! Voices
This discount chain is leaving the Kansas City area for good. Sales go until it’s gone - Yahoo! Voices
0.93%
3.55%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):